Indacaterol maleate is an ultra-long-acting β-adrenoceptor agonist used for the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma; it acts as a bronchodilator by relaxing airway smooth muscle through β2-adrenoceptor activation; it demonstrates potent and prolonged inhibition of bronchoconstriction induced by various spasmogens (e.g., carbachol, serotonin, and electrical field stimulation) in human and animal airways; it also shows anti-inflammatory potential by inhibiting IgE-dependent histamine release from mast cells.